Hazard Information | Back Directory | [Description]
SM-276001 is a selective and potent TLR7 agonist. SM-276001 is can induce antitumor immune responses when dosed either intratracheally or orally. Oral administration of SM-276001 leads to the induction of IFNα, TNFα and IL-12p40 and a reduction in tumor burden in the Balb/c syngeneic Renca and CT26 models. |
|
Company Name: |
cjbscvictory
|
Tel: |
13348960310 13348960310 |
Website: |
http://www.weikeqi-biotech.com/ |
|